Myocardial Infarction Activates CCR2+ Hematopoietic Stem and Progenitor Cells

•CCR2 expression identifies an HSPC subset that responds vigorously to ischemia•Myeloid translocation gene 16 (Mtg16) is necessary for the emergence of CCR2+ HSPCs•Absence of CCR2+ HSPCs associates with compromised infarct healing•CCR2+CD150+CD48− LSKs preferentially migrate outside of the bone marrow

SummaryFollowing myocardial infarction (MI), myeloid cells derived from the hematopoietic system drive a sharp increase in systemic leukocyte levels that correlates closely with mortality. The origin of these myeloid cells, and the response of hematopoietic stem and progenitor cells (HSPCs) to MI, however, is unclear. Here, we identify a CCR2+CD150+CD48− LSK hematopoietic subset as the most upstream contributor to emergency myelopoiesis after ischemic organ injury. This subset has 4-fold higher proliferation rates than CCR2−CD150+CD48− LSK cells, displays a myeloid differentiation bias, and dominates the migratory HSPC population. We further demonstrate that the myeloid translocation gene 16 (Mtg16) regulates CCR2+ HSPC emergence. Mtg16−/− mice have decreased levels of systemic monocytes and infarct-associated macrophages and display compromised tissue healing and post-MI heart failure. Together, these data provide insights into regulation of emergency hematopoiesis after ischemic injury and identify potential therapeutic targets to modulate leukocyte output after MI.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (161 K)Download as PowerPoint slide